Lucas Morin
Overview
Explore the profile of Lucas Morin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morin L, Weber V, Meijer G, Yu F, Staar P
Nat Commun
. 2025 Jan;
16(1):224.
PMID: 39747104
No abstract available.
2.
Soeiro T, Allouchery M, Bene J, Bezin J, Dolladille C, Faillie J, et al.
Therapie
. 2024 Dec;
PMID: 39706774
The drug authorization process is shifting towards a policy aimed at shortening time-to-market. While this policy facilitates early access to new treatments, it can also result in potentially insufficient knowledge...
3.
Steinmetz E, Cottenet J, Mariet A, Morin L, Bernard A, Bejot Y, et al.
Eur J Vasc Endovasc Surg
. 2024 Nov;
69(3):359-370.
PMID: 39490630
Objective: This retrospective, nationwide cohort study aimed to compare peri-procedural stroke or death within 30 days of the procedure (PPSD30) in patients who underwent carotid endarterectomy (CEA) or carotid stenting...
4.
Morin L, Weber V, Meijer G, Yu F, Staar P
Nat Commun
. 2024 Aug;
15(1):6532.
PMID: 39095357
The automatic analysis of patent publications has potential to accelerate research across various domains, including drug discovery and material science. Within patent documents, crucial information often resides in visual depictions...
5.
Bennie M, Santa-Ana-Tellez Y, Galistiani G, Trehony J, Despres J, Jouaville L, et al.
Br J Clin Pharmacol
. 2024 May;
90(9):2124-2136.
PMID: 38812250
Aims: The aims of this study were to measure the prevalence of polypharmacy and describe the prescribing of selected medications known for overuse in older people with polypharmacy in primary...
6.
Szilcz M, Wastesson J, Calderon-Larranaga A, Morin L, Lindman H, Johnell K
Front Oncol
. 2023 Oct;
13:1223563.
PMID: 37876970
Background: The appropriate time to discontinue chemotherapy at the end of life has been widely discussed. In contrast, few studies have investigated the patterns of endocrine treatment near death. In...
7.
Chazal E, Morin L, Chocron S, Lassalle P, Pili-Floury S, Salomon du Mont L, et al.
Cardiovasc Diabetol
. 2023 Aug;
22(1):221.
PMID: 37620974
Background: Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperative glycemic variability...
8.
Kirvalidze M, Abbadi A, Dahlberg L, Sacco L, Calderon-Larranaga A, Morin L
Res Synth Methods
. 2023 Jul;
14(5):764-767.
PMID: 37501239
Umbrella reviews (reviews of systematic reviews) are increasingly used to synthesize findings from systematic reviews. One important challenge when pooling data from several systematic reviews is publication overlap, that is,...
9.
Thompson W, Reeve E, McDonald E, Farrell B, Scott S, Steinman M, et al.
Basic Clin Pharmacol Toxicol
. 2023 May;
133(6):661-664.
PMID: 37142559
No abstract available.
10.
Kirvalidze M, Abbadi A, Dahlberg L, Sacco L, Morin L, Calderon-Larranaga A
BMJ Open
. 2023 Apr;
13(4):e068646.
PMID: 37085312
Objectives: This umbrella review aimed to evaluate whether certain interventions can mitigate the negative health consequences of caregiving, which interventions are more effective than others depending on the circumstances, and...